Instrumental Approaches in Neuropharmacological Screening: A Review of Insights from Electroconvulsiometer and Actophotometer Studies

The Electroconvulsiometer and Actophotometer are key experimental instruments in neuropharmacological research, widely employed for screening and evaluating the effects of central nervous system (CNS)–active agents. The Electroconvulsiometer functions by inducing controlled maximal electroshock seizures (MES) in rodents, providing a reliable and reproducible model for assessing the anticonvulsant efficacy of drugs, particularly those targeting generalized tonic–clonic seizures. The actophotometer assesses locomotor activity through infrared beam breaks produced by animal movement. This technique is valuable for evaluating the stimulant or depressant actions of CNS drugs, offering a non-invasive and quantitative method of behavioral analysis. Together, these instruments serve as indispensable tools in preclinical pharmacology, contributing to the discovery, characterization, and optimization of therapeutic compounds by facilitating objective assessment of their anticonvulsant, sedative, stimulant, and neuroprotective properties.